Search

Your search keyword '"Smith, Caleb"' showing total 1,832 results

Search Constraints

Start Over You searched for: Author "Smith, Caleb" Remove constraint Author: "Smith, Caleb"
1,832 results on '"Smith, Caleb"'

Search Results

56. Award rate inequities in biomedical research

59. Characterization of a high bandwidth readout chain for the CMS Phase-2 pixel upgrade

62. Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study

63. Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer

64. Relocation of an Extrasynaptic GABAA Receptor to Inhibitory Synapses Freezes Excitatory Synaptic Strength and Preserves Memory

67. Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A*02 (HLA-A*02) loss of heterozygosity (LOH).

72. Strengthened Euler's Inequality in Spherical and Hyperbolic Geometries

76. Hartt's Musical Radio Man -- The Informer

78. Examining crossover and postprotocol therapies in first‐line immunotherapy trials in non–small cell lung cancer.

81. Project Seaweed Submersible

82. A Comprehensive Optogenetic Pharmacology Toolkit for In Vivo Control of GABA(A) Receptors and Synaptic Inhibition.

83. Hartt's Hidden History: The Organ - The Informer

86. Northside Neighborhood Plan, Iowa City, Iowa

89. Restoring Visual Function to Blind Mice with a Photoswitch that Exploits Electrophysiological Remodeling of Retinal Ganglion Cells

90. 634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss of heterozygosity (LOH)

91. 636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials

92. 534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)

93. Analysis of Medicare Expenditure for Discarded Infused Cancer Therapeutics From 2017-2020

99. Search for Z' bosons decaying to pairs of heavy Majorana neutrinos in proton-proton collisions at $\sqrt{s}$ = 13 TeV

100. Two-particle Bose-Einstein correlations and their Levy parameters in PbPb collisions at $ \sqrt{\smash[b]{s_{_{\mathrm{NN}}}}} = $ 5.02 TeV

Catalog

Books, media, physical & digital resources